These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 6177374)
1. Purified interferon as protection against rhinovirus infection. Scott GM; Phillpotts RJ; Wallace J; Secher DS; Cantell K; Tyrrell DA Br Med J (Clin Res Ed); 1982 Jun; 284(6332):1822-5. PubMed ID: 6177374 [TBL] [Abstract][Full Text] [Related]
2. Failure of human fibroblast interferon to protect against rhinovirus infection. Scott GM; Reed S; Cartwright T; Tyrrell D Arch Virol; 1980; 65(2):135-9. PubMed ID: 6158933 [TBL] [Abstract][Full Text] [Related]
7. Recombinant human interferon-gamma as prophylaxis against rhinovirus colds in volunteers. Higgins PG; al-Nakib W; Barrow GI; Tyrrell DA J Interferon Res; 1988 Oct; 8(5):591-6. PubMed ID: 2853194 [TBL] [Abstract][Full Text] [Related]
8. Prevention of rhinovirus colds by human interferon alpha-2 from Escherichia coli. Scott GM; Phillpotts RJ; Wallace J; Gauci CL; Greiner J; Tyrrell DA Lancet; 1982 Jul; 2(8291):186-8. PubMed ID: 6177991 [No Abstract] [Full Text] [Related]
9. Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon. Hayden FG; Albrecht JK; Kaiser DL; Gwaltney JM N Engl J Med; 1986 Jan; 314(2):71-5. PubMed ID: 3001519 [TBL] [Abstract][Full Text] [Related]
10. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Turner RB Clin Infect Dis; 2001 Dec; 33(11):1865-70. PubMed ID: 11692298 [TBL] [Abstract][Full Text] [Related]
11. Effects on the nasal mucosa of upper respiratory viruses (common cold). Winther B Dan Med Bull; 1994 Apr; 41(2):193-204. PubMed ID: 8039434 [TBL] [Abstract][Full Text] [Related]
12. Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteers. Al-Nakib W; Higgins PG; Barrow I; Tyrrell DA; Lenox-Smith I; Ishitsuka H J Antimicrob Chemother; 1987 Dec; 20(6):887-92. PubMed ID: 3326874 [TBL] [Abstract][Full Text] [Related]
13. Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). al-Nakib W; Higgins PG; Barrow GI; Tyrrell DA; Andries K; Vanden Bussche G; Taylor N; Janssen PA Antimicrob Agents Chemother; 1989 Apr; 33(4):522-5. PubMed ID: 2543283 [TBL] [Abstract][Full Text] [Related]
14. Intranasal lymphoblastoid interferon ("Wellferon") prophylaxis against rhinovirus and influenza virus in volunteers. Phillpotts RJ; Higgins PG; Willman JS; Tyrrell DA; Freestone DS; Shepherd WM J Interferon Res; 1984; 4(4):535-41. PubMed ID: 6094684 [TBL] [Abstract][Full Text] [Related]
15. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults. Sperber SJ; Levine PA; Innes DJ; Mills SE; Hayden FG J Infect Dis; 1988 Jul; 158(1):166-75. PubMed ID: 2839579 [TBL] [Abstract][Full Text] [Related]
16. Intranasal interferon alpha 2 for prevention of rhinovirus infection and illness. Hayden FG; Gwaltney JM J Infect Dis; 1983 Sep; 148(3):543-50. PubMed ID: 6311914 [TBL] [Abstract][Full Text] [Related]
17. Trials of interferon in respiratory infections of man. Tyrrell DA Tex Rep Biol Med; 1977; 35():486-90. PubMed ID: 358470 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of an interferon inducer, N,N-dihexadecyl-m-xylylenediamine, on rhinovirus challenge in humans. Douglas RG; Waldman RH; Betts RF; Ganguly R Antimicrob Agents Chemother; 1979 Feb; 15(2):269-72. PubMed ID: 371545 [TBL] [Abstract][Full Text] [Related]